KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Common Equity (2016 - 2025)

Stereotaxis (STXS) has disclosed Common Equity for 16 consecutive years, with $13.5 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 121.73% to $13.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.5 million through Dec 2025, up 121.73% year-over-year, with the annual reading at $13.5 million for FY2025, 121.73% up from the prior year.
  • Common Equity for Q4 2025 was $13.5 million at Stereotaxis, up from $6.3 million in the prior quarter.
  • The five-year high for Common Equity was $36.5 million in Q2 2021, with the low at $1.5 million in Q2 2025.
  • Average Common Equity over 5 years is $20.2 million, with a median of $20.1 million recorded in 2023.
  • Peak annual rise in Common Equity hit 121.73% in 2025, while the deepest fall reached 87.18% in 2025.
  • Over 5 years, Common Equity stood at $33.8 million in 2021, then dropped by 22.15% to $26.3 million in 2022, then tumbled by 37.97% to $16.3 million in 2023, then tumbled by 62.8% to $6.1 million in 2024, then surged by 121.73% to $13.5 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $13.5 million, $6.3 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.